![]() Gradalis Gradalis is a biotechnology company focused on the development and commercialization of personalized therapeutics to treat cancer. | ![]() Immatics Immatics is a biotechnology company that is primarily engaged in the research and development of T cell redirecting immunotherapies for the treatment of cancer. | ![]() Vericel Vericel develops, manufactures, and markets autologous cell-based therapies for patients with serious diseases and conditions. | |
Founding Date | Founding Date 2003 | Founding Date N/A | Founding Date 1989 |
Type | Type Private | Type Public | Type Public |
Tags | |||
Locations | Locations Carrollton, US HQ | Locations Tübingen, DE HQ Frankfurt Am Main, DE München, DE Houston, US | Locations Cambridge, US HQ Ann Arbor, US |
Employees | Employees 25 | Employees 29723% increase | Employees 24112% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 1.1 b | Valuation ($) 2.2 b |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) €48.3m (FY, 2025) | Revenue (est.) $276.3m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods $70.7m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit €53m (FY, 2025) | Gross profit $205.6m (FY, 2025) |
Net income | Net income N/A | Net income (€196.4m) (FY, 2025) | Net income $16.5m (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 67.9m | Total funding raised $ 267.3m | Total funding raised N/A |

Immatics is a biotechnology company that is primarily engaged in the research and development of T cell redirecting immunotherapies for the treatment of cancer.
View company
Vericel develops, manufactures, and markets autologous cell-based therapies for patients with serious diseases and conditions.
View company